West to Host Third Quarter 2015 Conference Call

EXTON, PA -- (Marketwired) -- 10/22/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release third quarter 2015 financial results before the market opens on Thursday, October 29th, 2015, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 60682964.

A live broadcast of the conference call will be available at the Company's web site, www.westpharma.com, in the "Investors" section. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast. Management will refer to a slide presentation during the call, which will be made available on the day of the call. To view the presentation, select "Presentations" in the "Investors" section of the Company's website. The presentation will be in "PDF" format and, if needed, the website includes a link to a free download of software that will enable viewing of the PDF presentation.

An online archive of the broadcast will be available at the site three hours after the live call and will be available through Thursday, November 5th, 2015, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International) and entering conference ID 60682964.

About West

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2014 sales of $1.42 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.

Contacts:
West
Michael A. Anderson
Vice President and Treasurer
(610) 594-3345

Investors and Financial Media:
Westwicke Partners
John Woolford
(443) 213-0506

Source: West Pharmaceutical Services, Inc

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Hub Group faces credibility test as Q2 report looms Sept. 1
• Benchmark Reiterates Buy Rating on Malibu Boats (MBUU) on Significant Earnings Upside